Kliniske studier for Mani i California
5 studier for Mani søker deltakere på steder i California.
Byer i California
Offisiell studietekst (engelsk)
An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania
- Neurocrine Clinical Site, Cerritos
- Neurocrine Clinical Site, Garden Grove
- Neurocrine Clinical Site, San Diego
RekruttererFase 2
Alder 18 til 65 · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07288320A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
- Proscience Research Group, Culver City
- Clinical Innovations, Inc. dba CITrials, Riverside
- Collaborative Neuroscience Research, LLC, Torrance
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06951711A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
- Advanced Research Center Inc., Anaheim
- CITrials, Bellflower
- Local Institution - 0014, Cerritos
- og 3 flere
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06951698A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
- Advanced Research Center Inc., Anaheim
- Clinical Innovations, Inc. dba CITrials, Bellflower
- Local Institution - 0044, Cerritos
- og 10 flere
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 14. sep. 2026 · NCT06929273A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
- Clinical Innovations, Inc. dba CITrials, Bellflower
- Inland Psychiatric Medical Group., Chino
- Proscience Research Group, Culver City
- og 4 flere
RekruttererFase 3
Alder 18 til 65 · Alle kjønn · Oppdatert 23. jun. 2026 · NCT07140913Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.